These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


430 related items for PubMed ID: 17690036

  • 1. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
    Ding L, Chen XP, Zhang ZW, Jing K, Zhang WG.
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
    [Abstract] [Full Text] [Related]

  • 2. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 3. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L, Chen XP, Zhang ZW, Wang H, Cao B, Wang ZH, Li CL.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 01; 43(19):1248-53. PubMed ID: 16271222
    [Abstract] [Full Text] [Related]

  • 4. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G, Dong S, Qu J, Sun Z, Huang Z, Ye L, Liang H, Ai X, Zhang W, Chen X.
    Liver Int; 2010 Apr 01; 30(4):585-92. PubMed ID: 19780956
    [Abstract] [Full Text] [Related]

  • 5. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma.
    Song X, Wang JB, Yin DL, Yang HY, Liu LX, Jiang HC.
    Chin Med J (Engl); 2009 Nov 05; 122(21):2636-42. PubMed ID: 19951584
    [Abstract] [Full Text] [Related]

  • 7. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression.
    Zheng LH, Bao YL, Wu Y, Yu CL, Meng X, Li YX.
    Cancer Lett; 2008 Dec 08; 272(1):102-9. PubMed ID: 18703276
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice.
    Zhang ZM, Yang XY, Deng SH, Xu W, Gao HQ.
    Chin Med J (Engl); 2007 Aug 05; 120(15):1336-42. PubMed ID: 17711740
    [Abstract] [Full Text] [Related]

  • 9. [Establishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure].
    Zhai BJ, Wu F, Shao ZY, Hu K, Zhao CL, Wang ZB.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb 05; 12(2):95-8. PubMed ID: 14980111
    [Abstract] [Full Text] [Related]

  • 10. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L, Lang J, Shen K.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug 05; 32(8):462-6. PubMed ID: 9639738
    [Abstract] [Full Text] [Related]

  • 11. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y, Tang Z, Ye S, Liu Y, Chen J, Xue Q, Huang X, Chen J, Bao W, Yang J, Gao D.
    Zhonghua Yi Xue Za Zhi; 2002 May 10; 82(9):601-5. PubMed ID: 12133480
    [Abstract] [Full Text] [Related]

  • 12. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B, Ye T, Zhao L, Li DH, Gou XH, Zhao LY, Han L, Chen L, Yan LN, Gong JP.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 10; 5(4):552-9. PubMed ID: 17085341
    [Abstract] [Full Text] [Related]

  • 13. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb 10; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 14. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L, Chen L, Fei XH, Qiu HY, Zhou H, Wang JM.
    Chin Med J (Engl); 2006 Jun 05; 119(11):911-8. PubMed ID: 16780770
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical relationship between MDR1 gene and gallbladder cancer.
    Wang BL, Zhai HY, Chen BY, Zhai SP, Yang HY, Chen XP, Zhao WT, Meng L.
    Hepatobiliary Pancreat Dis Int; 2004 May 05; 3(2):296-9. PubMed ID: 15138130
    [Abstract] [Full Text] [Related]

  • 17. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
    Fantappiè O, Solazzo M, Lasagna N, Platini F, Tessitore L, Mazzanti R.
    Cancer Res; 2007 May 15; 67(10):4915-23. PubMed ID: 17510421
    [Abstract] [Full Text] [Related]

  • 18. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Yang H, Ding R, Tong Z, Huang J, Shen L, Sun YU, Liao J, Yang Z, Hoffman RM, Wang C, Meng X.
    Anticancer Res; 2016 Jun 15; 36(6):2675-82. PubMed ID: 27272776
    [Abstract] [Full Text] [Related]

  • 19. Effects of P-glycoprotein modulation on the chemotherapy of xenotransplanted human hepatoblastoma.
    Warmann SW, Heitmann H, Teichmann B, Gratz KF, Ruck P, Hunger M, Fuchs J.
    Pediatr Hematol Oncol; 2005 Jun 15; 22(5):373-86. PubMed ID: 16020127
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.